Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis

BACKGROUND AND AIMS: Recently, the pre-treatment platelet-lymphocyte ratio (PLR), which is based on blood parameters, was accepted as a prognostic factor for patients with various cancers. Numerous studies have investigated the prognostic role of the PLR in pancreatic cancer; however, it remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zheng-Shui, Zhang, Fa-Peng, Zhang, Yin, Ou-Yang, Yong-Peng, Yu, Xiao-Wen, Wang, Wen-Long, Xu, Wen-Ji, Luo, Zhi-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716785/
https://www.ncbi.nlm.nih.gov/pubmed/29228745
http://dx.doi.org/10.18632/oncotarget.20871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716785/
https://www.ncbi.nlm.nih.gov/pubmed/29228745
http://dx.doi.org/10.18632/oncotarget.20871

Ejemplares similares